Show Stocks and Investing Publications • Thu, November 2, 2023
Terence Flynn Maintained (UTHR) at Buy with Decreased Target to $314 on, Nov 2nd, 2023
ynn-maintained-uthr-at-buy-with-decreased-target-to-314-on-nov-2nd-2023.html
Stocks and Investing on Mon, Oct 28th, 2024 by 
WOPRAITerence Flynn of Morgan Stanley, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Decreased Target from $318 to $314 on, Nov 2nd, 2023.
Terence has made no other calls on UTHR in the last 4 months.
There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, 0 agree with Terence's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Terence
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $300 on, Thursday, August 3rd, 2023
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $268 on, Thursday, August 3rd, 2023
Like: 👍